Quarterly report · Q1
2796.TEDINET S100S04W
Period2023-06-01 → 2023-08-31
Filed2023-10-11
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 34
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥13.5bn | 2023-06-01 → 2023-08-31 | Cons. | Net sales |
| Revenue | ¥52.0bn | 2022-06-01 → 2023-05-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥12.9bn | 2022-06-01 → 2022-08-31 | Cons. | Net sales |
| Operating income | ¥331m | 2023-06-01 → 2023-08-31 | Cons. | Operating income |
| Operating income | ¥348m | 2022-06-01 → 2022-08-31 | Cons. | Operating income |
| Ordinary income | ¥331m | 2023-06-01 → 2023-08-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.4bn | 2022-06-01 → 2023-05-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥341m | 2022-06-01 → 2022-08-31 | Cons. | Ordinary income |
| Profit before tax | ¥312m | 2023-06-01 → 2023-08-31 | Cons. | Income before income taxes |
| Profit before tax | ¥318m | 2022-06-01 → 2022-08-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥123m | 2023-06-01 → 2023-08-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥333m | 2022-06-01 → 2023-05-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥111m | 2022-06-01 → 2022-08-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥127m | 2023-06-01 → 2023-08-31 | Cons. | Profit loss |
| Net income | ¥114m | 2022-06-01 → 2022-08-31 | Cons. | Profit loss |
| Total assets | ¥23.6bn | at 2023-08-31 | Cons. | Assets |
| Total assets | ¥23.4bn | at 2023-05-31 | Cons. | Assets |
| Total assets | ¥23.2bn | at 2022-08-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥16.6bn | at 2023-08-31 | Cons. | Liabilities |
| Total liabilities | ¥16.4bn | at 2023-05-31 | Cons. | Liabilities |
| Net assets / equity | ¥7.0bn | at 2023-08-31 | Cons. | Net assets |
| Net assets / equity | ¥7.0bn | at 2023-05-31 | Cons. | Net assets |
| Net assets / equity | ¥6.7bn | at 2022-08-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥4.9bn | at 2023-08-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥4.7bn | at 2023-05-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥13.11 | 2023-06-01 → 2023-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥35.45 | 2022-06-01 → 2023-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥11.88 | 2022-06-01 → 2022-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥9.93 | 2023-06-01 → 2023-08-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥26.89 | 2022-06-01 → 2023-05-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥8.99 | 2022-06-01 → 2022-08-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 28.3% | at 2023-08-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 28.5% | at 2023-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 27.6% | at 2022-08-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 44
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-06-01 → 2023-08-31 | ¥185m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-06-01 → 2023-08-31 | ¥185m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-06-01 → 2023-08-31 | ¥0 |
| Reconciling Itemsreconciling | segment profit | 2023-06-01 → 2023-08-31 | −¥78m |
| jpcrp040300-q1r_E05379-000Cosmetic Drug And Convenience Storereportable segment | revenue | 2023-06-01 → 2023-08-31 | ¥2.1bn |
| jpcrp040300-q1r_E05379-000Cosmetic Drug And Convenience Storereportable segment | revenue external | 2023-06-01 → 2023-08-31 | ¥2.1bn |
| jpcrp040300-q1r_E05379-000Cosmetic Drug And Convenience Storereportable segment | segment profit | 2023-06-01 → 2023-08-31 | −¥9m |
| jpcrp040300-q1r_E05379-000Custody Of Medical Documentsreportable segment | revenue | 2023-06-01 → 2023-08-31 | ¥155m |
| jpcrp040300-q1r_E05379-000Custody Of Medical Documentsreportable segment | revenue external | 2023-06-01 → 2023-08-31 | ¥155m |
| jpcrp040300-q1r_E05379-000Custody Of Medical Documentsreportable segment | segment profit | 2023-06-01 → 2023-08-31 | ¥11m |
| jpcrp040300-q1r_E05379-000Dispensing Pharmacyreportable segment | revenue | 2023-06-01 → 2023-08-31 | ¥10.9bn |
| jpcrp040300-q1r_E05379-000Dispensing Pharmacyreportable segment | revenue external | 2023-06-01 → 2023-08-31 | ¥10.9bn |
| jpcrp040300-q1r_E05379-000Dispensing Pharmacyreportable segment | segment profit | 2023-06-01 → 2023-08-31 | ¥379m |
| jpcrp040300-q1r_E05379-000Medical Mallreportable segment | revenue | 2023-06-01 → 2023-08-31 | ¥126m |
| jpcrp040300-q1r_E05379-000Medical Mallreportable segment | revenue external | 2023-06-01 → 2023-08-31 | ¥126m |
| jpcrp040300-q1r_E05379-000Medical Mallreportable segment | segment profit | 2023-06-01 → 2023-08-31 | ¥27m |
| —segment total | revenue | 2023-06-01 → 2023-08-31 | ¥13.3bn |
| —segment total | revenue external | 2023-06-01 → 2023-08-31 | ¥13.3bn |
| —segment total | segment profit | 2023-06-01 → 2023-08-31 | ¥408m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-06-01 → 2023-08-31 | ¥13.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-06-01 → 2023-08-31 | ¥13.5bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-06-01 → 2023-08-31 | ¥409m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-06-01 → 2022-08-31 | ¥204m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-06-01 → 2022-08-31 | ¥204m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-06-01 → 2022-08-31 | ¥21m |
| Reconciling Itemsreconciling | segment profit | 2022-06-01 → 2022-08-31 | −¥75m |
| jpcrp040300-q1r_E05379-000Cosmetic Drug And Convenience Storereportable segment | revenue | 2022-06-01 → 2022-08-31 | ¥2.0bn |
| jpcrp040300-q1r_E05379-000Cosmetic Drug And Convenience Storereportable segment | revenue external | 2022-06-01 → 2022-08-31 | ¥2.0bn |
| jpcrp040300-q1r_E05379-000Cosmetic Drug And Convenience Storereportable segment | segment profit | 2022-06-01 → 2022-08-31 | −¥35m |
| jpcrp040300-q1r_E05379-000Custody Of Medical Documentsreportable segment | revenue | 2022-06-01 → 2022-08-31 | ¥169m |
| jpcrp040300-q1r_E05379-000Custody Of Medical Documentsreportable segment | revenue external | 2022-06-01 → 2022-08-31 | ¥169m |
| jpcrp040300-q1r_E05379-000Custody Of Medical Documentsreportable segment | segment profit | 2022-06-01 → 2022-08-31 | ¥20m |
| jpcrp040300-q1r_E05379-000Dispensing Pharmacyreportable segment | revenue | 2022-06-01 → 2022-08-31 | ¥10.4bn |
| jpcrp040300-q1r_E05379-000Dispensing Pharmacyreportable segment | revenue external | 2022-06-01 → 2022-08-31 | ¥10.4bn |
| jpcrp040300-q1r_E05379-000Dispensing Pharmacyreportable segment | segment profit | 2022-06-01 → 2022-08-31 | ¥398m |
| jpcrp040300-q1r_E05379-000Medical Mallreportable segment | revenue | 2022-06-01 → 2022-08-31 | ¥126m |
| jpcrp040300-q1r_E05379-000Medical Mallreportable segment | revenue external | 2022-06-01 → 2022-08-31 | ¥126m |
| jpcrp040300-q1r_E05379-000Medical Mallreportable segment | segment profit | 2022-06-01 → 2022-08-31 | ¥19m |
| —segment total | revenue | 2022-06-01 → 2022-08-31 | ¥12.7bn |
| —segment total | revenue external | 2022-06-01 → 2022-08-31 | ¥12.7bn |
| —segment total | segment profit | 2022-06-01 → 2022-08-31 | ¥402m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-06-01 → 2022-08-31 | ¥12.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-06-01 → 2022-08-31 | ¥12.9bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-06-01 → 2022-08-31 | ¥424m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 375
| Item | Context | Value | Unit |
|---|---|---|---|
| Current portion of long term loans payable | Prior1YearInstant | 2008000000 | JPY |
| Current portion of long term loans payable | CurrentQuarterInstant | 1826000000 | JPY |
| Income taxes payable | Prior1YearInstant | 333000000 | JPY |
| Income taxes payable | CurrentQuarterInstant | 185000000 | JPY |
| Provision for bonuses | Prior1YearInstant | 45000000 | JPY |
| Provision for bonuses | CurrentQuarterInstant | 273000000 | JPY |
| Provision for loss on store closing | Prior1YearInstant | 21000000 | JPY |
| Provision for loss on store closing | CurrentQuarterInstant | 20000000 | JPY |
| Other cl | Prior1YearInstant | 1691000000 | JPY |
| Other cl | CurrentQuarterInstant | 1153000000 | JPY |
| Current liabilities | Prior1YearInstant | 9835000000 | JPY |
| Current liabilities | CurrentQuarterInstant | 9861000000 | JPY |
| Long term loans payable | Prior1YearInstant | 5216000000 | JPY |
| Long term loans payable | CurrentQuarterInstant | 5327000000 | JPY |
| Net defined benefit liability | Prior1YearInstant | 791000000 | JPY |
| Net defined benefit liability | CurrentQuarterInstant | 807000000 | JPY |
| Asset retirement obligations ncl | Prior1YearInstant | 111000000 | JPY |
| Asset retirement obligations ncl | CurrentQuarterInstant | 112000000 | JPY |
| Other ncl | Prior1YearInstant | 478000000 | JPY |
| Other ncl | CurrentQuarterInstant | 461000000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 6598000000 | JPY |
| Noncurrent liabilities | CurrentQuarterInstant | 6709000000 | JPY |
| Liabilities | Prior1YearInstant | 16433000000 | JPY |
| Liabilities | CurrentQuarterInstant | 16570000000 | JPY |
| Capital stock | Prior1YearInstant | 1298000000 | JPY |
| Capital stock | CurrentQuarterInstant | 1298000000 | JPY |
| Capital surplus | Prior1YearInstant | 1553000000 | JPY |
| Capital surplus | CurrentQuarterInstant | 1553000000 | JPY |
| Retained earnings | Prior1YearInstant | 4014000000 | JPY |
| Retained earnings | CurrentQuarterInstant | 4005000000 | JPY |
| Treasury stock | Prior1YearInstant | -210000000 | JPY |
| Treasury stock | CurrentQuarterInstant | -210000000 | JPY |
| Shareholders equity | Prior1YearInstant | 6655000000 | JPY |
| Shareholders equity | CurrentQuarterInstant | 6647000000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | -0 | JPY |
| Valuation difference on available for sale securities | CurrentQuarterInstant | -0 | JPY |
| Remeasurements of defined benefit plans | Prior1YearInstant | 18000000 | JPY |
| Remeasurements of defined benefit plans | CurrentQuarterInstant | 18000000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 17000000 | JPY |
| Valuation and translation adjustments | CurrentQuarterInstant | 17000000 | JPY |
| Subscription rights to shares | Prior1YearInstant | 208000000 | JPY |
| Subscription rights to shares | CurrentQuarterInstant | 208000000 | JPY |
| Non controlling interests | Prior1YearInstant | 105000000 | JPY |
| Non controlling interests | CurrentQuarterInstant | 109000000 | JPY |
| Net assets | Prior1YearInstant | 6987000000 | JPY |
| Net assets | CurrentQuarterInstant | 6983000000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 23421000000 | JPY |
| Liabilities and net assets | CurrentQuarterInstant | 23553000000 | JPY |
| Net sales | Prior1YTDDuration | 12861000000 | JPY |
| Net sales | CurrentYTDDuration | 13471000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |